iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 119.66 billion as of April 28, 2026. Its market cap has increased by 7.12% in one year.

Market Cap

119.66B

Enterprise Value

81.24B

Revenue

5.74B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,740.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 119.66B, an increase of 25.56%. That is a compound annual growth rate of 1.50%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	119.66B	16.46%
Dec 30, 2025	102.75B	-44.03%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Oncocross	111.59B
Prestige BioPharma	108.89B
Amicogen	133.16B
IMB Dx	99.95B
CG Invites	97.66B
GeneOne Life Science	83.06B
Vaxcell-Bio Therapeutics	178.38B
ENCell	181.08B

Market Cap Rankings